Treatment guidelines for DIFICID® (fidaxomicin)
2021 IDSA/SHEA guidelines
Watch and listen as a key opinion leader in the industry discusses the 2021 Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) guideline recommendations.
Dr. Paul Feuerstadt, MD, FACG, AGAF: Assistant Clinical Professor of Medicine, Yale New Haven Hospital – Bridgeport Hospital. Attending Gastroenterologist, PACT Gastroenterology Center.
View excerpts from the 2021 IDSA/SHEA clinical practice guidelines for patients with Clostridioides difficile infection (CDI)1
2021 ACG guidelines
View excerpts from the 2021 ACG clinical guidelines for patients with Clostridioides difficile infection (CDI)2
References
- Johnson S, Lavergne V, Skinner AM, et al. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. Clinical Infectious Diseases. Published online June 14, 2021. doi:10.1093/cid/ciab549
- Kelly CR, Fischer M, Allegretti JR, et al. 2021 ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections. Am J Gastroenterol.
2021;10.14309/ajg.0000000000001278. doi:10.14309/ajg.0000000000001278